My watch list
my.bionity.com  
Login  

7 Newest Market Studies about the topic orphan drug designation

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher’s and Niemann-Pick Poised to Supersede Existing Therapies

GBI Research has released its latest research, “Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such as Gaucher’s and Niemann-Pick Poised to Supersede Existing Therapies” which provides insights into global neurometabolic disorders market and market forecast until ...

more

Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic SWOT Analysis Review

Vanda Pharmaceuticals Inc. (Vanda), is a biopharmaceutical company, engaged in developing and commercializing clinical-stage drug candidates targeting central nervous system disorders. Recently, the company and its development partner Novartis Pharmaceuticals Corporation have launched Fanapt ...

more

Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Pharmaceuticals, Inc. (Provectus) is a biotechnology company, that is engaged in the development of oncology and dermatology therapies. The company's product pipeline includes PV-10, an injectable formulation of rose bengal designed to selectively target and destroy cancer cells without ...

more

Repligen Corporation (RGEN) - Financial and Strategic SWOT Analysis Review

Repligen Corporation (Repligen) is a publicly held research focused bio pharmaceutical company engaged in development of innovative therapeutics for neurological disorders. Repligen offers recombinant protein A, immobilized protein A and protein A ELISA kits under its marketed product portfolio. ...

more

Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic SWOT Analysis Review

Talecris Biotherapeutics Holdings Corp (Talecris) is a publicly held pharmaceutical company. It is engaged in the development, production, marketing and distribution of therapies for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), ...

more

Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic SWOT Analysis Review

Cyclacel Pharmaceuticals, Inc. (Cyclacel) is a publicly held US-based bio pharmaceutical company. The company is principally engaged in the discovery, development and commercialization of mechanism-targeted drugs employed for the treatment of human cancers and other serious disorders. The ...

more

iBio, Inc. (IBPM) - Financial and Strategic SWOT Analysis Review

iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE